Kayne Anderson Rudnick Investment Management
MRNA icon

Kayne Anderson Rudnick Investment Management’s Moderna MRNA Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19
Closed -$524 – 1085
2025
Q2 		$524 Buy
+19
New +$500 ﹤0.01% 988
2024
Q4 		– Sell
-21,719
Closed -$1.45M – 1016
2024
Q3 		$1.45M Sell
21,719
-654
-3% -$60K ﹤0.01% 365
2024
Q2 		$2.66M Sell
22,373
-503
-2% -$63.7K 0.01% 315
2024
Q1 		$2.44M Sell
22,876
-822
-3% -$82.9K 0.01% 321
2023
Q4 		$2.36M Sell
23,698
-1,022
-4% -$86K 0.01% 327
2023
Q3 		$2.55M Sell
24,720
-186
-0.7% -$20.7K 0.01% 329
2023
Q2 		$3.03M Sell
24,906
-374
-1% -$49.9K 0.01% 323
2023
Q1 		$3.88M Hold
25,280
– – 0.01% 308
2022
Q4 		$4.54M Sell
25,280
-1,070
-4% -$175K 0.01% 301
2022
Q3 		$3.12M Buy
+26,350
New +$4M 0.01% 311
2022
Q2 		– Sell
-6
Closed -$1K – 653
2022
Q1 		$1K Buy
6
+1
+20% +$168 ﹤0.01% 638
2021
Q4 		$1K Buy
+5
New +$1.46K ﹤0.01% 619

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return